Epoetin beta

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin beta
Drug Alias NameEpoch (Roche)罗可曼依泊汀βEpoetinum beta (Roche)促红素β +[17] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsIschemiaAsphyxia NeonatorumAnemia +[11] 
Global Approved IndicationsAnemiaKidney Failure, Chronic
Approved Indications in ChinaAnemia
Original Approved Country/TerritoryEU
Original Approved Date1997/07/16
Country/TerritoryCzechiaBelgiumUnited States +[32] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoche Pharma (Switzerland) LtdChugai Pharmaceutical Co LtdRoche Registration Gmbh
Inactive CompaniesRoche Foundation Of Anemia Research (Rofar, Switzerland)Roche Pharma AgUniversity of Zurich +[10] 
Active IndicationsAnemiaKidney Failure, Chronic
Inactive IndicationsIschemiaAsphyxia NeonatorumMyocardial Ischemia +[9] 

Other Information

ATC CodeB03XA01
Related LinksWikipediaDrugBankKEGG